Lv12
40 积分 2026-01-22 加入
Bruton's Tyrosine Kinase Inhibitors in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Meta-analysis and Systematic Review
11小时前
待确认
Efficacy and safety of ibrutinib in central nervous system lymphoma: A systematic review and meta-analysis
11小时前
已完结
Meta‐analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma
11小时前
已完结
皖公网安备34019202002308
